Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease.

Scientific reports | 2017

Huntington's disease is characterized by a complex and heterogeneous pathogenic profile. Studies have shown that disturbance in lipid homeostasis may represent a critical determinant in the progression of several neurodegenerative disorders. The recognition of perturbed lipid metabolism is only recently becoming evident in HD. In order to provide more insight into the nature of such a perturbation and into the effect its modulation may have in HD pathology, we investigated the metabolism of Sphingosine-1-phosphate (S1P), one of the most important bioactive lipids, in both animal models and patient samples. Here, we demonstrated that S1P metabolism is significantly disrupted in HD even at early stage of the disease and importantly, we revealed that such a dysfunction represents a common denominator among multiple disease models ranging from cells to humans through mouse models. Interestingly, the in vitro anti-apoptotic and the pro-survival actions seen after modulation of S1P-metabolizing enzymes allows this axis to emerge as a new druggable target and unfolds its promising therapeutic potential for the development of more effective and targeted interventions against this incurable condition.

Pubmed ID: 28706199 RIS Download

Associated grants

  • Agency: NIEHS NIH HHS, United States
    Id: R01 ES010563
  • Agency: NIEHS NIH HHS, United States
    Id: R01 ES016931

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


GE Healthcare (tool)

RRID:SCR_000004

A commercial antibody supplier and provider of various services.

View all literature mentions

Quantity One 1-D Analysis Software (tool)

RRID:SCR_014280

Software used for Bio-Rad imaging systems to acquire, quantitate, and analyze a variety of data. The software allows automatic configuration of imaging systems with appropriate filters, lasers, LEDs, and other illumination sources. It also contains tools for automated analysis of tests and assays such as 1-D electrophoretic gels, western blots, and colony counts.

View all literature mentions

B6CBA-Tg(HDexon1)62Gpb/1J (tool)

RRID:IMSR_JAX:002810

Mus musculus with name B6CBA-Tg(HDexon1)62Gpb/1J from IMSR.

View all literature mentions

STHdhQ7/111 (cell line)

RRID:CVCL_DN41

Cell line STHdhQ7/111 is a Transformed cell line with a species of origin Mus musculus

View all literature mentions

STHdhQ7 (cell line)

RRID:CVCL_M590

Cell line STHdhQ7 is a Transformed cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

STHdhQ7/111 (cell line)

RRID:CVCL_DN41

Cell line STHdhQ7/111 is a Transformed cell line with a species of origin Mus musculus

View all literature mentions

STHdhQ7 (cell line)

RRID:CVCL_M590

Cell line STHdhQ7 is a Transformed cell line with a species of origin Mus musculus (Mouse)

View all literature mentions